Dr. Stuart Lander, MD
What this data tells you about Dr. Lander
Dr. Stuart Lander is a cardiovascular disease in Arlington, TX, with 19 years in practice. Based on federal Medicare data, Dr. Lander performed 3,339 Medicare services across 2,314 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lander received a total of $65,593 from 44 pharmaceutical and/or device companies across 616 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lander is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote pacemaker/defibrillator monitoring, 90 days | 563 | $16 | $70 |
| Electrocardiogram (EKG), 12-lead | 459 | $10 | $47 |
| Remote pacemaker monitoring, 90 days | 429 | $21 | $135 |
| Office visit, established patient (30-39 min) | 408 | $89 | $220 |
| Echocardiogram, transthoracic | 220 | $140 | $800 |
| Programming of dual lead pacemaker system | 175 | $55 | $129 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 133 | $25 | $150 |
| Hospital follow-up visit, moderate complexity | 93 | $57 | $150 |
| Office visit, established patient (20-29 min) | 91 | $63 | $150 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 69 | $9 | $25 |
| Ultrasound of both sides of head and neck blood flow | 65 | $132 | $510 |
| Regadenoson injection (Lexiscan) for heart stress test | 61 | $43 | $150 |
| Evaluation of implantable heart and blood vessel monitoring system | 48 | $33 | $135 |
| New patient office visit (45-59 min) | 41 | $121 | $335 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 40 | $12 | $135 |
| Programming of single lead pacemaker system | 39 | $48 | $110 |
| Replacement of aortic valve through the skin and femoral artery | 33 | $551 | $2,800 |
| Initial hospital admission, moderate complexity | 26 | $94 | $280 |
| Injection, perflutren lipid microspheres, per ml | 26 | $36 | $330 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 25 | $346 | $2,500 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 25 | $48 | $190 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 25 | $36 | $400 |
| Programming of dual lead implantable defibrillator system | 24 | $60 | $180 |
| Programming of multiple lead implantable defibrillator system | 23 | $73 | $192 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 23 | $152 | $800 |
| Ultrasound of heart blood flow, valves and chambers | 22 | $39 | $190 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $18 | $190 |
| Heart muscle strain imaging | 19 | $29 | $82 |
| Cardiac catheterization | 19 | $163 | $996 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 19 | $244 | $805 |
| Coronary stent placement | 14 | $394 | $3,000 |
| Ultrasound of leg arteries or artery grafts | 13 | $175 | $820 |
| Initial hospital admission, high complexity | 13 | $136 | $410 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $395 | $1,400 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 11 | $9 | $40 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $16 | $55 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (51%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for cardiovascular disease in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lander is a electrophysiology & remote specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 9%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lander experienced with remote pacemaker/defibrillator monitoring, 90 days?
Does Dr. Lander receive payments from pharmaceutical companies?
How do Dr. Lander's costs compare to other cardiovascular diseases in Arlington?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology